AU2019266276A1 - Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same - Google Patents

Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same Download PDF

Info

Publication number
AU2019266276A1
AU2019266276A1 AU2019266276A AU2019266276A AU2019266276A1 AU 2019266276 A1 AU2019266276 A1 AU 2019266276A1 AU 2019266276 A AU2019266276 A AU 2019266276A AU 2019266276 A AU2019266276 A AU 2019266276A AU 2019266276 A1 AU2019266276 A1 AU 2019266276A1
Authority
AU
Australia
Prior art keywords
retinal
rpe
cells
rpe cells
3dnr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019266276A
Other languages
English (en)
Inventor
Silvia APARICIO DOMINGO
Maria Valeria CANTO-SOLER
Miguel FLORES BELLVER
Kang Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Colorado Colorado Springs
Original Assignee
University of Colorado System
University of Colorado Colorado Springs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Colorado System, University of Colorado Colorado Springs filed Critical University of Colorado System
Publication of AU2019266276A1 publication Critical patent/AU2019266276A1/en
Priority to AU2025226710A priority Critical patent/AU2025226710A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • C12N2502/083—Coculture with; Conditioned medium produced by cells of the nervous system sensory transducers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/08—Coculture with; Conditioned medium produced by cells of the nervous system
    • C12N2502/085—Coculture with; Conditioned medium produced by cells of the nervous system eye cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2527/00—Culture process characterised by the use of mechanical forces, e.g. strain, vibration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/164—Retinal disorders, e.g. retinopathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acoustics & Sound (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
AU2019266276A 2018-05-09 2019-05-09 Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same Abandoned AU2019266276A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025226710A AU2025226710A1 (en) 2018-05-09 2025-09-03 Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862669133P 2018-05-09 2018-05-09
US62/669,133 2018-05-09
US201962826196P 2019-03-29 2019-03-29
US62/826,196 2019-03-29
PCT/US2019/031442 WO2019217630A1 (en) 2018-05-09 2019-05-09 Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025226710A Division AU2025226710A1 (en) 2018-05-09 2025-09-03 Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same

Publications (1)

Publication Number Publication Date
AU2019266276A1 true AU2019266276A1 (en) 2020-12-03

Family

ID=66625387

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019266276A Abandoned AU2019266276A1 (en) 2018-05-09 2019-05-09 Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same
AU2025226710A Pending AU2025226710A1 (en) 2018-05-09 2025-09-03 Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025226710A Pending AU2025226710A1 (en) 2018-05-09 2025-09-03 Stem cell-derived cell cultures, stem cell-derived three-dimensional tissue products, and methods of making and using the same

Country Status (5)

Country Link
US (1) US20210317403A1 (cg-RX-API-DMAC7.html)
EP (1) EP3790959A1 (cg-RX-API-DMAC7.html)
JP (2) JP7473210B2 (cg-RX-API-DMAC7.html)
AU (2) AU2019266276A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019217630A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2906815A1 (en) 2013-03-15 2014-09-18 Ocata Therapeutics, Inc. Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
US11241460B2 (en) 2013-03-15 2022-02-08 Astellas Institute For Regenerative Medicine Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
CA3074426A1 (en) 2017-09-08 2019-03-14 Sumitomo Dainippon Pharma Co., Ltd. Cell aggregate including retinal tissue and production method therefor
WO2020218480A1 (ja) 2019-04-26 2020-10-29 国立研究開発法人理化学研究所 神経網膜と網膜色素上皮細胞とハイドロゲルとを含む複合体及びその製造方法
GB2584664B (en) * 2019-06-10 2023-05-24 Newcells Biotech Ltd Improved retinal organoids and methods of making the same
JP2025515075A (ja) * 2022-05-04 2025-05-13 ザ・ジョンズ・ホプキンス・ユニバーシティー 光受容体移植処置のための細胞を選別する方法
WO2024143436A1 (ja) 2022-12-28 2024-07-04 株式会社VC Cell Therapy 網膜シートの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
RU2580898C1 (ru) 2013-04-25 2016-04-10 Вуджин Инк. Ультразвуковая система измерения потока
AU2014362722B2 (en) 2013-12-11 2021-06-10 Riken Method for manufacturing ciliary marginal zone-like structure
WO2015109148A1 (en) 2014-01-16 2015-07-23 The Johns Hopkins University Methods for forming three-dimensional human retinal tissue in vitro
US20210155895A1 (en) * 2016-04-04 2021-05-27 Lineage Cell Therapeutics, Inc. Pluripotent Stem Cell-Derived 3D Retinal Tissue and Uses Thereof

Also Published As

Publication number Publication date
EP3790959A1 (en) 2021-03-17
JP7834367B2 (ja) 2026-03-24
WO2019217630A1 (en) 2019-11-14
JP2021522822A (ja) 2021-09-02
AU2025226710A1 (en) 2025-09-25
JP2024086789A (ja) 2024-06-28
JP7473210B2 (ja) 2024-04-23
US20210317403A1 (en) 2021-10-14

Similar Documents

Publication Publication Date Title
JP7834367B2 (ja) 幹細胞由来の細胞培養物、幹細胞由来の三次元組織製品、及びそれらの製造及び使用方法
US20230028133A1 (en) Methods of treating retinal diseases
AU2025283562A1 (en) Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
EP3047017B1 (en) Methods of mammalian retinal stem cell production and applications
JP2022084697A (ja) 神経変性を治療するための方法及び組成物
KR20220088800A (ko) 만능 세포를 분화시키는 방법
JP2023089154A (ja) 網膜疾患治療法の治療効果を測定する方法
WO2017190136A1 (en) Induction of corneal endothelial cells
CN117320733A (zh) 包含三维球状体型细胞聚集体来源细胞外囊泡的用于促进神经再生的组合物
EP2139989B1 (en) An isolated population of cells and methods of generating and using same
US20240108501A1 (en) Apparatus and methods for delivery of cell compositions
WO2018081616A1 (en) Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction
JP2015505459A (ja) ポリカプロラクトン基質を用いたヒト網膜前駆細胞からの光受容体の生成方法
US20260007701A1 (en) Anticancer composition comprising stem cell-derived exosomes and preparation method therefor
Xia Retinal stem cell culture on planar scaffold for transplantation in animal models of retinal degeneration
CA3268934A1 (en) Apparatus and methods for delivery of cell compositions
US20220177837A1 (en) Geometric induction of pluripotency
Jones Development of methods for retinal ganglion cell replacement in glaucoma
HK40066083A (en) Methods of treating retinal diseases

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted